Source: Eden Empire
  • Eden Empire (EDEN) announces its first store opening in British Columbia
  • The store located at 4317 Fraser Street opened to the public on July 30
  • EDEN intends to expand in Canada and to grow its cultivation, extraction and processing‎ while becoming a vertically ‎integrated company
  • EDEN is in the business of investments and operations in the cannabis sector and engaging ‎in retail cannabis sales
  • It is expected to have a significant retail cannabis footprint in Canada and Michigan
  • EDEN Empire Inc. (EDEN) is trading at C$0.04 at 12:50 pm ET

EDEN Empire (EDEN) is pleased to announce the opening of the first EDEN retail location in Vancouver, through a Sub-License & Operating Agreement.

The store, located at 4317 Fraser Street, is operational and open to the public as of July 30, 2021.

Gerry Trapasso, CEO & Director commented,

“The launch of the first EDEN branded location in Vancouver signifies a momentous moment for EDEN. The Agreement creates great exposure for EDEN and shows the power behind the EDEN brand and its rigorous client services.”

“We are confident that the launch of EDEN’s street-style brand in the East-Van market will give the local neighbourhood something to talk about,” added Trapasso.

EDEN is in the business of investments and operations in the cannabis sector and engaging ‎in retail cannabis sales. EDEN intends to expand its retail operations in Canada and to ‎expand its business to cannabis cultivation, extraction and processing‎ and become a vertically ‎integrated cannabis product company in the United States. ‎

Upon completion of EDEN’s currently intended acquisitions, and approval to operate its retail locations, it is expected to have a significant retail cannabis footprint in Canada and Michigan. Retail cannabis operations are an emerging sector ‎with significant cash flow potential. ‎

EDEN Empire Inc. (EDEN) is trading at C$0.04 at 12:50 pm ET.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.